HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES


SEVİNDİK Ö. G., GÜÇ Z., KAHRAMAN S., SOLMAZ MEDENİ Ş., KATGI A., ACAR C., ...More

THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES, Washington, Kiribati, 29 April - 02 May 2015, vol.39, pp.123 identifier

  • Publication Type: Conference Paper
  • Volume: 39
  • Doi Number: 10.1016/s0145-2126(15)30248-4
  • City: Washington
  • Country: Kiribati
  • Page Numbers: pp.123
  • Istanbul Medipol University Affiliated: Yes